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ABSTRACT  
 
Arterial fibromuscular dysplasia (FMD) is a non-inflammatory, non-atherosclerotic, occlusive 
condition of the systemic arteries, most frequently affecting renal arteries. Renal cell carcinoma 
(RCC)  might be associated with arterial hypertension, however, there are no data in the literature 
regarding  the relationship between RCC and associated renal artery changes. 
We analyzed a consecutive series of 57 (35 male and 22 female) patients aging from 35 to 79 
years (mean 58.9 years) who underwent nephrectomy due to RCC in the year 2003. The patients 
had RCC measuring from 2-16 cm (mean 7.1 cm). Specimens were routinely fixed, embedded in 
paraffin, cut and stained with hematoxylin and eosin, Mallory trichrome method and orcein. 
Renal arteries of 26 patients (20 male, 6 female) showed no changes. In these patients RCC 
measured 2.5-11 cm in largest diameter (mean 6.6 cm). In 24 patients (10 male, 14 female)  renal 
arteries showed FMD. RCCs in these patients measured between 2-16 cm (mean 8.0 cm). Seven 
patients had atherosclerotic changes in renal arteries. 
In this series FMD was found in a significant proportion of patients with RCC, mainly in women. 
The cause of such changes and their relationship with RCC and systemic hypertension should be 
further analyzed. 
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INTRODUCTION 
 
The renal arteries arise from the abdominal aorta at the level of L2 and the right renal artery is 
longer than the left one. Different lesions may involve main renal artery including 
atherosclerosis, fibromuscular dysplasia and some other conditions, such as Takayasu arteritis, 
radiation injury and congenital malformations [11]. 
Arterial fibromuscular dysplasia (FMD) is a non-inflammatory, non-atherosclerotic, occlusive 
condition of systemic arteries, the renal arteries being most frequently affected. Major clinical 
conditions associated with FMD are hypertension, stroke, claudication and intestinal ischemia 
[7]. FMD of renal arteries is bilateral in nearly half of patients, more commonly on the right side 
(3:1); is usually diagnosed in the fourth decade, with female predominance and most frequently 
involving the distal two thirds of the renal artery and its branches [11, 12].  Incidence of the FMD 
found at autopsy study is about 1% [4, 8]. 
There are three principal pathologic types of FMD: intimal, medial and adventitial fibromuscular 
dysplasia. Primary intimal fibroplasia (type I) is a rare condition that occurs in children and 
young adults, comprising about 2% to 5% of all FMD lesions [3, 9, 14, 15] and sometimes it can 
be difficult to distinguish this type of FMD from non-specific fibrosis as seen in atherosclerosis 
[9]. This type can be connected with progressive renal artery obstruction and ischemic atrophy of 
the kidney [3]. Medial fibromuscular dysplasia (type II) can be further subdivided into three 
subtypes: medial “muscular” hyperplasia (type IIa), medial fibroplasia with aneurysms (type IIb) 
and perimedial fibroplasias (type IIc) of which medial fibroplasia is the most common type of 
FMD (about 70%). The lesion usually affects women aging 25 to 50 years, with bilateral 
involvement in about 60% [3, 9]. Adventitial fibroplasia (type III) is very rare and represents less 
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than 1% of all FMDs [3]. 
Atherosclerosis is a generalized progressive arterial disease associated with localized arterial 
occlusions and aneurysms [11]. It accounts for 90 % of the cases of renal-artery stenosis and 
usually involves the ostium and proximal third of the main renal artery and perirenal aorta [12]. 
Renal cell carcinoma (RCC) represents 2% of all human malignancies and over 90% of all 
malignancies of the kidney. It is two to three times more common in men than in women and the 
average age at diagnosis is 55 to 60 years [2, 11]. History of blood hypertension, obesity and 
tobacco smoking increases the risk of RCC [1, 11]. 
The aim of this study was to analyze renal artery changes in patients with renal cell carcinoma. 
 
MATERIALS AND METHODS 
 
A consecutive series of 74 patients aging from 35-79 years with RCC who underwent 
nephrectomy in the year 2003 (44 male and 30 female) was analyzed. Seventeen patients (9 male 
and 8 female) were excluded from the study because 5 of them had only partial nephrectomy, 2 
were sent for consultation from other hospitals (without renal arteries), in 4 cases renal arteries 
were tangentially cut and in 6 specimens renal arteries were not sampled. Finally, the study group 
consisted of 57 patients. All relevant patients’ data including age, sex, tumor grade and size, the 
extent of tumor necrosis, blood pressure and vena cava status were analyzed. There were 35 male 
and 22 female patients with RCC ranging in age from 35-79 years (mean 58.9 years). The size of 
RCC was from 2-16 cm (mean 7.1 cm). Renal artery, and vein as well as ureter margin were 
routinely analyzed. Specimens were routinely fixed in 10% buffered formaldehyde, embedded in 
paraffin, cut and stained with hematoxylin and eosin, Mallory trichrome method and orcein, and 
examined by light microscopy. Immunohistochemistry was performed by Microwave 
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Streptavidine Immunoperoxidase protocol (MSIP) in DAKO TechMateTM Horizon automated 
immunostainer. We used primary antibodies to smooth muscle actin (SMA) that were purchased 
from DAKO, Copenhagen, Denmark. Dilution of the antibody was "ready to use". Nuclear grade 
of RCC was determined according to Fuhrmann et al [4]. 
Statistical analysis used in this study included F-test, T-test/Cochran-Cox method, and χ2-test. 
Level of significance was set at p<0.05. 
The classification of FMD included pathologic processes of intimal, medial and adventitial 
fibroplasia [3, 9, 15]. 
 
RESULTS 
 
Renal arteries of 26 patients (20 male and 6 female) ranging in age from 38-74 years (mean 58.6 
years) showed no changes. RCC in these patients measured 2.5-11 cm in largest diameter (mean 
6.6 cm). In 24 patients (M: F=10:14) aging from 35-79 years (mean 60.0 years) renal arteries 
showed FMD (Figure 1), and RCC in these patients were between 2-16 cm (mean 8 cm), while 7 
patients (5 male and 2 female) aging 60-69 years (mean 62.0 years) had atherosclerotic changes 
in renal arteries. Tumor size in this group was 2.5-14 cm (mean 6.4 cm).  In the first group (cases 
without renal artery changes) there were 3 patients with tumorous infiltration of the renal vein. 
The same number of cases with renal vein infiltration was found in the second group 
(fibromuscular changes of renal arteries) while only one patient from the third group who had 
atherosclerotic changes of renal arteries had tumorous infiltration of renal vein. Blood pressure in 
patients from the first group was from 100/70 to 160/100 mmHg (mean 125/84.5 mmHg), in the 
second group  110/80 to 200/100 mmHg (mean 138.5/86 mmHg) and in the third group 115/70 to 
145/85 mmHg (mean 134/79 mmHg). There were no data about the blood pressure for 14 
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(24.6%) patients.  Four patients with no renal artery changes and 5 patients from the second 
group (FMD) were receiving antihypertensive therapy. Necrosis was observed in 45 of 57 tumors 
(78.9%). There was no statistically significant correlation between the presence (p=0.750) and 
type (p=0.052) of FMD and the extent of the necrosis in RCCs. Tumors with type I of FMD 3/7 
(42.9%) showed more than 50% necrosis, while only 1/15 (6.7%) tumors with FMD type IIb had 
the same extent of necrosis. One of two cases with FMD type IIa showed necrosis in more than 
50% of tumor mass. 
Clinicopathologic features of patients with renal cell carcinoma are shown in Table 1 and 2. 
Statistical analysis showed no significant difference in the age (p=0.486), tumor size (p=0.112) 
and mean systolic (p=0.918) and diastolic (p=0.448) blood pressure between the first and the 
second group of patients. However, FMD was found significantly more often in female patients 
(p=0.009). Furthermore, there was no statistically significant difference in the age, tumor size and 
blood pressure between the first and third group and second and third group of patients. In the 
group of patients with atherosclerosis and without significant pathomorphologic changes of renal 
arteries men were more frequent (p=0.028).  
 
DISCUSSION 
The incidence of RCC is significantly higher in people with a history of blood hypertension that 
is not dependent on obesity and tobacco smoking. One of the causes of hypertension is renal-
artery stenosis due to atherosclerosis in 90 percent of cases [12]. 
Fibromuscular dysplasia accounts for less than 10 percent of cases of renal artery stenosis, the 
medial type representing about 90 percent of cases [8, 14]. 
 Atherosclerotic renal artery stenosis is a common and progressive disease, however it is 
probable that many atherosclerotic stenoses are never detected because refractory hypertension or 
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renal failure does not develop [12]. In the hypertensive population, high blood pressure may be 
attributed to renovascular FMD in less than 2% of patients [15]. In patients with renovascular 
hypertension, FMD is the underlying cause in 20-50% of cases [8]. The ethiology of FMD is 
unknown, although many theories have been advanced, including those involving a genetic 
predisposition, smoking, hormonal factors and disorders of vasa vasorum as risk factors [8, 14]. 
The patients with FMD may be asymptomatic and the natural history of the disease is relatively 
benign with progression occurring in only the minority of patients [8]. 
In our previous study fibromuscular dysplasia of renal arteries was found in a significant 
proportion of patients with RCC, mainly in females [7]. These changes might be primary, but 
also could be the result of some other factor or the effect of the tumor itself.   
Hypertension has been implicated as a risk factor for the development of RCC, but quantitative 
data concerning the levels of blood pressure are limited [1]. A small case-control study based on 
medical records found that the risk of RCC was higher with higher blood pressure within 5 to 10 
years before the diagnosis of RCC. In the study with long-term follow-up, Chow et al [1] showed 
that blood pressure was positively related to the risk of RCC. The risk of RCC in men with 
diastolic pressure of 90 mmHg or more was more than double the risk in men with diastolic 
pressure below 70 mmHg. Similar data were reported on the relationship and risk for systolic 
pressure [1, 13]. 
 In our study, renal artery changes were observed in 31 out of 57 patients with RCC. There 
was no correlation between blood pressure and the presence of FMD.  
 There are few studies on the relation between RCC and blood pressure that were based on 
relatively small number of subjects except for the study of Chow et al [1] on 363.992 Swedish 
men in whom 759 RCC developed during the 25 years period of follow-up. 
 Grossly, RCC usually shows large areas of necrosis. Such changes are usually attributed 
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to some abnormalities in tumor vascularization. The data in the literature pointed out to the 
relationship between the presence and extent of tumor necrosis in RCC and different features 
including tumor size, cell type, nuclear grade as well as microvessel density and the expression of 
different markers [6]. However, there are no data about the relationship between fibromuscular 
dysplasia like changes and renal cell carcinoma. Onishi et al reported histological features of 
hypovascular and avascular RCC, however, the cause of vascular changes was not furtherly 
analyzed [10]. We observed tumor necrosis in 78.9% of tumors, but there was no statistically 
significant correlation between the presence and type of FMD and the extent of the necrosis of 
RCC. However, it seems that a larger study is needed to confirm the relationship between FMD 
type and tumor necrosis. 
On the basis of our results we may conclude that fibromuscular dysplasia of renal artery 
occurs in a significant proportion of female patients with renal cell carcinoma, while male 
patients more frequently had atherosclerosis or no pathomorphologic renal artery changes. 
However further studies are needed to elucidate these changes and to determine whether are 
primary or represent a consequence of the tumor.  
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Table 1.  Clinicopathologic features of 57 patients with renal cell carcinoma with regard to 
renal artery status (Group I - without artery changes, Group II - FMD, Group III - 
atherosclerosis)  
 
 Group I Group II Group III 
Male 20 10 5 
Female 6 14 2 
Age 38-74 years (mean 58.6) 35-79 years (mean 60.0) 60-69 years (mean 62.0) 
Tumor size 2.5-11 cm (mean 6.6) 2-16 cm (mean 8) 2.5-14 cm (mean 6.4) 
Tumor necrosis Less than 50% - 21 
More than 50% - 5 
Less than 50% - 19 
More than 50% - 5 
Less than 50% - 6 
More than 50% - 1 
Blood pressure 110/70-160/100 mmHg 
(mean 125/84.5) 
110/80-200/100 mmHg 
(mean 138.5/86) 
115/70-145/85 mmHg 
(mean 134/79) 
Cell type of RCC Clear cell-10 
Chromophilic 
eosinophilic-5, 
Mixed (Clear and 
eosinophilic)-7  
Mixed with sarcomatoid 
component-3 
Chromophobe-1 
Clear cell-8 
Chromophilic 
eosinophilic-3 
Mixed (Clear and 
eosinophilic)-8  
Mixed with sarcomatoid 
component-5 
Clear cell-5 
Chromophilic 
eosinophilic-1 
Mixed with sarcomatoid 
component-1 
Nuclear grade G1 - 3 
G2 - 7 
G3 - 10 
G4 – 6 
G1 - 0 
G2 - 8 
G3 - 9 
G4 - 7 
G1 - 1 
G2 - 6 
G3 - 0 
G4 - 0 
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Table 2.  Clinicopathologic features of 57 patients with RCC regarding three different types of 
FMD (Type I - intimal, Type IIa - medial muscular, Type IIb - medial fibromuscular) 
 
 Type I Type IIa Type IIb 
Male 3 0 7 
Female 4 2 8 
Age 52-74 years (mean 62) 35-66 years (mean 50) 36-79 years (mean 
60.5) 
Tumor size 2-14 cm (mean 7.4) 6-12 cm (mean 9.0) 3-16 cm (mean 8.0) 
Blood pressure 120/70-200/100 mmHg 
(mean 150/90) 
120/80-140/95 mmHg 
(maen 130/87.5) 
110/80-175/95 mmHg 
(mean 136.3/84.2) 
Nuclear grade Predominantly G3 Predominantly G2 Equally G2,3 i 4 
Cell type of RCC Clear cell-2 
Chromophilic 
eosinophilic-1 
Mixed (Clear and 
eosinophilic)-3 
Mixed with sarcomatoid 
component-1 
Chromophilic 
eosinophilic-2 
Clear cell-6 
Chromophilic 
eosinophilic-1 
Mixed (Clear and 
eosinophilic-3 
Mixed with 
sarcomatoid 
component-5 
Tumor necrosis Less than 50% - 4 
More than 50% - 3 
Less than 50% - 1 
More than 50% - 1 
Less than 50% - 14 
More than 50% - 1 
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Figure 1. Renal artery dysplasia of medial fibromuscular type IIb in a patient with renal cell 
carcinoma, A – Hematoxylin and eosin stained section showing protrusion of fibromuscular 
ridge into the arterial lumen, B – Mallory stained section showing proliferation of smooth 
muscle and connective tissue, C – Orcein stained section showing the internal lamina D – 
Smooth muscle actin (SMA) immunostaining showing architectural disarray of the smooth 
muscle cells. (All microphotographs were made under low magnification, 40X.) 
     
     
 
